Biomarkers for tau pathology DOI Creative Commons
Michael Schöll, Anne Maaß, Niklas Mattsson

et al.

Molecular and Cellular Neuroscience, Journal Year: 2018, Volume and Issue: 97, P. 18 - 33

Published: Dec. 6, 2018

The aggregation of fibrils hyperphosphorylated and C-terminally truncated microtubule-associated tau protein characterizes 80% all dementia disorders, the most common neurodegenerative disorders. These so-called tauopathies are hitherto not curable their diagnosis, especially at early disease stages, has traditionally proven difficult. A keystone in diagnosis was development methods to assess levels vivo cerebrospinal fluid, which significantly improved our knowledge about these conditions. Tau proteins have also been measured blood, but importance tau-related changes blood is still unclear. recent addition positron emission tomography ligands visualize, map quantify pathology further contributed with information temporal spatial characteristics accumulation living brain. Together, measurement fluid biomarkers constitutes basis for a highly active field research. This review describes current state derived from neuroimaging analysis bodily fluids roles detection, prognosis tau-associated as well associations neuropathological findings, aims provide perspective on how might be employed prospectively research clinical settings.

Language: Английский

Meningeal Immunity and Its Function in Maintenance of the Central Nervous System in Health and Disease DOI Open Access
Kalil Alves de Lima, Justin Rustenhoven, Jonathan Kipnis

et al.

Annual Review of Immunology, Journal Year: 2020, Volume and Issue: 38(1), P. 597 - 620

Published: April 26, 2020

Neuroimmunology, albeit a relatively established discipline, has recently sparked numerous exciting findings on microglia, the resident macrophages of central nervous system (CNS). This review addresses meningeal immunity, less-studied aspect neuroimmune interactions. The meninges, triple layer membranes—the pia mater, arachnoid and dura mater—surround CNS, encompassing cerebrospinal fluid produced by choroid plexus epithelium. Unlike adjacent brain parenchyma, meninges contain wide repertoire immune cells. These constitute which is primarily concerned with surveillance and—according to recent evidence—also participates in postinjury CNS recovery, chronic neurodegenerative conditions, even higher function. Meningeal immunity come under spotlight owing characterization lymphatic vessels draining CNS. Here, we current state our understanding its effects healthy diseased brains.

Language: Английский

Citations

264

α-Synuclein pathology in Parkinson’s disease and related α-synucleinopathies DOI
Michael X. Henderson, John Q. Trojanowski, Virginia M.‐Y. Lee

et al.

Neuroscience Letters, Journal Year: 2019, Volume and Issue: 709, P. 134316 - 134316

Published: June 3, 2019

Language: Английский

Citations

229

B and T Cells Driving Multiple Sclerosis: Identity, Mechanisms and Potential Triggers DOI Creative Commons
Jamie van Langelaar, Liza Rijvers, Joost Smolders

et al.

Frontiers in Immunology, Journal Year: 2020, Volume and Issue: 11

Published: May 8, 2020

Historically, multiple sclerosis (MS) has been viewed as being primarily driven by T cells. However, the effective use of anti-CD20 treatment now also reveals an important role for B cells in MS patients. The results from this put forward T-cell activation rather than antibody production a driving force behind MS. main question how their interaction provokes both and to infiltrate CNS cause local pathology remains be answered. In review, we highlight key pathogenic events involving that most likely contribute pathogenesis These include 1) peripheral escape cell-mediated control, 2) secondary lymph nodes, 3) reactivation accumulating CNS. We will focus on functional programs CNS-infiltrating lymphocyte subsets patients discuss these are defined mechanisms such antigen presentation, co-stimulation cytokine periphery. Furthermore, potential impact genetic variants viral triggers candidate debated context

Language: Английский

Citations

229

COVID-19 and chronic fatigue syndrome: Is the worst yet to come? DOI Open Access
Peter Wostyn

Medical Hypotheses, Journal Year: 2021, Volume and Issue: 146, P. 110469 - 110469

Published: Jan. 1, 2021

Language: Английский

Citations

220

Biomarkers for tau pathology DOI Creative Commons
Michael Schöll, Anne Maaß, Niklas Mattsson

et al.

Molecular and Cellular Neuroscience, Journal Year: 2018, Volume and Issue: 97, P. 18 - 33

Published: Dec. 6, 2018

The aggregation of fibrils hyperphosphorylated and C-terminally truncated microtubule-associated tau protein characterizes 80% all dementia disorders, the most common neurodegenerative disorders. These so-called tauopathies are hitherto not curable their diagnosis, especially at early disease stages, has traditionally proven difficult. A keystone in diagnosis was development methods to assess levels vivo cerebrospinal fluid, which significantly improved our knowledge about these conditions. Tau proteins have also been measured blood, but importance tau-related changes blood is still unclear. recent addition positron emission tomography ligands visualize, map quantify pathology further contributed with information temporal spatial characteristics accumulation living brain. Together, measurement fluid biomarkers constitutes basis for a highly active field research. This review describes current state derived from neuroimaging analysis bodily fluids roles detection, prognosis tau-associated as well associations neuropathological findings, aims provide perspective on how might be employed prospectively research clinical settings.

Language: Английский

Citations

193